Sponsored Content

Capabilities to Successfully Develop and Manufacture HPAPIs

Lonza's Michiya Hayakawa provides an overview of the current market and presents strategies for manufacturing highly potent active drugs.

Company Logo

Released By Lonza

Request more information from Lonza

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters